Arcus Biosciences Inc. (RCUS)
Market Closed
24 Feb, 20:00
NYSE NYSE Primary $
20. 19
+1.34
+7.11%
$
1.91B Market Cap
- P/E Ratio
- Div Yield
1,449,759 Volume
-3.48 Eps
$ 18.85
Previous Close Day Range
19.43 21.19
Year Range
6.5 26.4
Want to track RCUS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
RCUS earnings report is expected in 1 days (25 Feb 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
RCUS Earnings Reports FAQ
What is the earnings per share (EPS) for RCUS?
The current EPS is -3.48.
What is the company's earnings growth rate?
Arcus Biosciences Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-02-24, based on the RCUS's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Arcus Biosciences Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for RCUS at this time, as Arcus Biosciences Inc has no recent EPS data to calculate it.
